Plasmapheresis Market Is Rising at 8.3% CAGR By 2022



The incidence of many autoimmune, hematologic, and metabolic diseases is seen increasing in the recent past. For instance, according to JDRF; the prevalence of type 1 diabetes in people under age of 20 has increased by 21% between 2001 and 2009. The U.S. is expected to have 5 million people affected with type 1 diabetes by 2050, of which 6,00,000 will be youth. Plasmapheresis is used as the first line treatment in insulin dependents, type 1 diabetes mellitus children, and critically ill adult diabetes patients. Hence, rising number of type 1 diabetes patients drives the adoption of this procedure. Similarly, according to The Arthritis Society, around 4.6 million Canadians aged 15 years and older were suffering from arthritis in 2015, of which around one million people living with rheumatoid arthritis. The society estimated that by 2036, the number of arthritis affected people will be 7.5 million. Plasmapheresis is used as aninitial treatment for rheumatoid arthritis. Thus rising incidence of various autoimmune diseases and growing adoption of TPE in their treatment is expected to drive the growth of plasmapheresis market during the forecast period.


Recently, Meticulous Research has published a comprehensive report on the “Plasmapheresis Market: Global Opportunity Analysis and Industry Forecasts to 2022”. According to Meticulous Research estimates, the global plasmapheresis market is projected to reach USD 1,285.3 million by 2022.

The global plasmapheresis market is oligopolies with top three players accounting for major share of the market in 2016. The major players providing plasmapheresis instrument and disposables in the global plasmapheresis market are B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), Baxter International Inc. (U.S.), Terumo Corporation (Japan), Kawasumi Laboratories Inc. (Japan), Haemonetics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Kaneka Corporation (Japan), Infomed SA (Switzerland), and Shanghai Dahua Medical Apparatus Co., Ltd. (China).


About Meticulous Research®
Meticulous Research® is founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Contact Us:

Viren Shrivastava

AVP- Global Sales and Marketing
Meticulous Research®
Tel: +1-646-781-8004


Comments

Popular posts from this blog

Organic fertilizers market : Top-10 Companies

Recreational Boats Market By Type (Inboard And Sterndrive Boats, Outboard, Sailboats), Material (Fiberglass, Wood, Inflatable), Application (Fishing, Travel & Tourism, Defense) – Global Opportunity Analysis And Industry Forecast (2017-2023)

Spirulina: The Greatest Super Food On Earth?